伊之密(300415) - 2021 Q4 - 年度财报

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the fiscal year 2021, representing a year-on-year growth of 15%[21]. - The net profit attributable to shareholders was RMB 200 million, an increase of 10% compared to the previous year[21]. - The company's operating revenue for 2021 was CNY 3,532,869,321.42, representing a 29.97% increase from CNY 2,718,203,896.35 in 2020[32]. - The net profit attributable to shareholders for 2021 was CNY 516,026,016.46, up 64.24% from CNY 314,181,341.83 in 2020[32]. - The basic earnings per share for 2021 was CNY 1.18, reflecting a 59.46% increase from CNY 0.74 in 2020[32]. - The company achieved total revenue of ¥3,532,869,321.42, representing a year-on-year growth of 29.97%[50]. - The net profit attributable to shareholders was ¥516,026,016.46, reflecting a year-on-year increase of 64.24%[50]. - The company reported a revenue of 3,355,440,639.46 CNY, with a gross margin of 33.92%, reflecting a year-on-year increase of 28.39% in revenue[68]. - The company reported a total remuneration of CNY 11.5963 million for directors, supervisors, and senior management in 2021[161]. Market Expansion and Strategy - The company is focusing on expanding its market presence in Southeast Asia, targeting a 25% market share by 2025[21]. - The company has established a global strategy with factories in India and service centers in Germany, Brazil, and Vietnam to expand its overseas market presence[47]. - The company plans to enhance its international market presence, with over 40 overseas distributors covering more than 70 countries and regions[59]. - The company is currently investing in two major projects, with total actual investment reaching ¥390,979,597.18[107]. - The company has completed a strategic acquisition of a local competitor for 300 million RMB, expected to enhance production capacity by 30%[156]. - Market expansion plans include entering two new international markets by the end of 2022, targeting a 10% increase in global market share[156]. Research and Development - The company has invested RMB 50 million in R&D for advanced molding technologies, aiming to enhance product quality and reduce production costs[21]. - R&D investment totaled ¥155,467,882.83, marking a 21.49% increase compared to the previous year[57]. - The company is investing 100 million RMB in R&D for new technologies, focusing on automation and precision machinery[156]. - The company aims to break the reliance on imported high-end equipment through its R&D efforts in super-large injection molding technology[89]. - The company has maintained a strong core competitive advantage with over 700 R&D personnel and more than 200 patented technologies[58]. Operational Efficiency - The management highlighted the importance of risk management strategies to mitigate potential impacts from market fluctuations and supply chain disruptions[21]. - The company has effectively controlled operating expenses, leading to a decrease in financial costs during the reporting period[56]. - The overall production efficiency has improved significantly due to the implementation of lean production lines in the injection molding machine sector[56]. - The company aims to reduce operational costs by 15% through efficiency improvements in the supply chain[156]. Shareholder Returns - The company plans to distribute a cash dividend of RMB 5.00 per 10 shares, based on a total of 469,145,684 shares[7]. - The board of directors has approved a dividend payout of 0.5 RMB per share, reflecting a commitment to returning value to shareholders[156]. - The cash dividend policy complies with the company's articles of association and ensures the protection of minority shareholders' rights[183]. Risk Management - The company faces risks from the ongoing pandemic, which has impacted production and overseas business expansion, and is actively adjusting its operations to mitigate these effects[124]. - The company confirmed that there were no significant risks affecting the performance of major contracts[75]. - The company faces risks related to high inventory levels due to the nature of its customized products, which have a production and sales cycle of approximately 2-8 months[127]. - The company is implementing measures to manage inventory risks, including optimizing procurement processes and enhancing warehouse control to improve inventory turnover[127]. Corporate Governance - The audit committee held 4 meetings during the reporting period, discussing key financial reports and proposals[171]. - All directors attended the board meetings via communication methods, with no absences reported[166]. - The company did not face any objections from the board regarding company matters during the reporting period[169]. - The company has implemented a robust internal control system in compliance with relevant laws and regulations, enhancing governance and operational efficiency[200]. - Continuous improvement and optimization of key business processes have been prioritized to strengthen internal controls and risk management capabilities[200].